Regeneron Pharmaceuticals: what changed between November 9, 2025 and November 9, 2026

Between 2025-11-09 and 2026-11-09, Regeneron Pharmaceuticals's record changed in 18 facts: 4 replaced (net income $4.41 billion → $4.5 billion; operating income $3.99 billion → $3.58 billion; research and development $5.13 billion → $5.85 billion and 1 more), 7 added, 7 ended; 11 unchanged.

state as of 2025-11-09 · state as of 2026-11-09 · timeline · markdown · JSON

Replaced (4)

the same fact with a different value

net income$4.41 billion2024-12-31 to 2025-12-31→$4.5 billionfrom 2025-12-31 · valid: Two independent sources agree, or a primary source states it: the record asserts this claim. · sec.gov: 1 source, claim clm_7514724ED5E9
operating income$3.99 billion2024-12-31 to 2025-12-31→$3.58 billionfrom 2025-12-31 · valid: Two independent sources agree, or a primary source states it: the record asserts this claim. · sec.gov: 1 source, claim clm_1B456AFB0CC5
research and development$5.13 billion2024-12-31 to

Added (7)

held on 2026-11-09, not on 2025-11-09

Added: 7 claims, with their dates, status and sources
fact	value	valid from	valid to	status	source
cash and equivalents	$3.66 billion claim → to present · sec.gov: 1 source, claim clm_5EBA4C72A92F	2026-09-30	present	valid: Two independent sources agree, or a primary source states it: the record asserts this claim.	sec.gov: 1 source, claim clm_5EBA4C72A92F
quarterly net income	$1.95 billion claim →

Ended (7)

held on 2025-11-09, not on 2026-11-09, and not replaced

Ended: 7 claims, with their dates, status and sources
fact	value	valid from	valid to	status	source
cash and equivalents	$2.51 billion claim → to 2025-12-31 · sec.gov: 1 source, claim clm_5CC511D1F933	2025-09-30	2025-12-31	superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.	sec.gov: 1 source, claim clm_5CC511D1F933
quarterly net income	$1.46 billion

What the statuses mean

Unchanged (11)

11 claims held on both days: CEO 1, CFO 1, SEC CIK 1, fiscal year end 1, headquarters 1, listed on 1, registrant name 1, shares outstanding 1, SIC industry 1, incorporated in 1, ticker 1.

quarterly operating income	$2.05 billion claim → to present · sec.gov: 1 source, claim clm_4585DB96888D	2026-09-30	present	valid: Two independent sources agree, or a primary source states it: the record asserts this claim.	sec.gov: 1 source, claim clm_4585DB96888D

quarterly research and development	$1.79 billion claim → to present · sec.gov: 1 source, claim clm_4D8C13296D0A	2026-09-30	present	valid: Two independent sources agree, or a primary source states it: the record asserts this claim.	sec.gov: 1 source, claim clm_4D8C13296D0A

quarterly revenue	$5.12 billion claim → to present · sec.gov: 1 source, claim clm_15BDC7B1496E	2026-09-30	present	valid: Two independent sources agree, or a primary source states it: the record asserts this claim.	sec.gov: 1 source, claim clm_15BDC7B1496E

total assets	$44.41 billion claim → to present · sec.gov: 1 source, claim clm_F46BE3EF6472	2026-09-30	present	valid: Two independent sources agree, or a primary source states it: the record asserts this claim.	sec.gov: 1 source, claim clm_F46BE3EF6472

total equity	$33.5 billion claim → to present · sec.gov: 1 source, claim clm_24A29A7153C0	2026-09-30	present	valid: Two independent sources agree, or a primary source states it: the record asserts this claim.	sec.gov: 1 source, claim clm_24A29A7153C0

quarterly operating income	$1.03 billion claim → to 2026-03-31 · sec.gov: 1 source, claim clm_0F41A2F44A01	2025-09-30	2026-03-31	superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.	sec.gov: 1 source, claim clm_0F41A2F44A01

quarterly research and development	$1.48 billion claim → to 2026-03-31 · sec.gov: 1 source, claim clm_F00F9DA4362C	2025-09-30	2026-03-31	superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.	sec.gov: 1 source, claim clm_F00F9DA4362C

quarterly revenue	$3.75 billion claim → to 2026-03-31 · sec.gov: 1 source, claim clm_471EC2DBAE0B	2025-09-30	2026-03-31	superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.	sec.gov: 1 source, claim clm_471EC2DBAE0B

total assets	$40.17 billion claim → to 2025-12-31 · sec.gov: 1 source, claim clm_A47C41C5A48C	2025-09-30	2025-12-31	superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.	sec.gov: 1 source, claim clm_A47C41C5A48C

total equity	$30.96 billion claim → to 2025-12-31 · sec.gov: 1 source, claim clm_CF9BA729AF1E	2025-09-30	2025-12-31	superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.	sec.gov: 1 source, claim clm_CF9BA729AF1E